The trajectory of Viagra presents a interesting case for stakeholders in the medicinal sector. While initially a phenomenal success, producing huge profits, the exclusivity expiration and the subsequent flood of https://pharma562132.blog5.net/94234803/viagra-and-pharma-a-hazardous-investment